Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

NCT00332137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Health

Interventions

DRUG: Tolterodine

Sponsor

Mayo Clinic

Collaborators

[object Object]